Quest Diagnostics Acquires Cleveland HeartLab, Formalizes R&D Collaboration

We represented Quest Diagnostics (NYSE: DGX) in its acquisition of Cleveland HeartLab. The acquisition combines the expertise of Cleveland HeartLab’s personalized evaluation of heart disease risk based on inflammation and other markers with Quest’s Cardio IQ® lipid particle analysis and genetic and metabolic testing leadership. In connection with the acquisition, Quest Diagnostics and Cleveland Clinic have also finalized a strategic collaboration intended to speed the commercialization of emerging innovations at Cleveland Clinic, including its Lerner Research Institute. Terms of the transaction were not publicly disclosed.

Quest Diagnostics is the world’s leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions.

You Also May Be Interested In:

  • Co-counsel to Methodist Le Bonheur Healthcare (MLH) in its efforts to obtain a Certificate of Need (CON) to initiate radiation therapy at its hospital campus located in Germantown, Tennessee

    Bass, Berry & Sims served as co-counsel to Methodist Le Bonheur Healthcare (MLH) in its efforts to obtain a Certificate...
    Client Type: Nonprofit
  • Represented Tivity Health, Inc. in its acquisition of Nutrisystem, Inc.

    We represented Tivity Health, Inc. (Nasdaq: TVTY) in its acquisition of Nutrisystem, Inc. (Nasdaq: NTRI), a provider of weight management...
    Client Type: Public Company
  • Served as main counsel on the recent Columbus Crew acquisition by a private investor group led by Dee and Jimmy Haslam (Crew SC Holdings)

    We served as main counsel on the recent Columbus Crew acquisition by a private investor group led by Dee and...
    Client Type: Private Company